Tirzepatide may only temporarily suppress brain activity involved in "food noise", suggests study Dr. Kamal Kant Kohli24 Nov 2025 9:00 PM ISTA rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, ...
Explainer Video: Acknowledge- Assisting Patients Through Challenges in Their Diabetes Care Journey Deeksha Bhandari22 Nov 2025 12:01 PM IST Weight management is an important but challenging part of type 2 diabetes care, especially for people with overweight or obesity. Even...
Tirzepatide Linked to Higher Risk of Osteoporosis and Fracture compared to other GLP-1 receptor agonists: Study Dr Riya Dave18 Nov 2025 8:30 PM ISTResearchers have found in a new large real-world cohort study that starting tirzepatide was associated with a significantly increased risk of...
Semaglutide, tirzepatide, and dulaglutide have similar Gl safety profiles in clinical settings, suggests study Dr. Kamal Kant Kohli18 Nov 2025 9:15 AM ISTA new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients...
Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide Dr. Kamal Kant Kohli13 Nov 2025 8:15 PM ISTInjectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical...
Medical Bulletin 12/November/2025 Dr. Bhumika Maikhuri12 Nov 2025 4:00 PM ISTHere are the top medical news for the day:Targeted Vitamin D Therapy Cuts Risk of Repeat Heart Attack by Half: Study Finds A new study has reported...
Semaglutide and Tirzepatide Cut Heart Risks in Type 2 Diabetes: Study Finds Dr. Bhumika Maikhuri12 Nov 2025 8:30 AM ISTA new database study has found that the injectable weight-loss drugs semaglutide and tirzepatide significantly reduce the risk of serious ...
Explainer video: Advise- Educating Patients about Addressing Glycemic and Weight Goals Deeksha Bhandari11 Nov 2025 11:45 AM ISTTalking about excess weight with people living with type 2 diabetes can be sensitive, but it is an important part of diabetes care. Evidence shows...
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India's Top-Selling Drug Farhat Nasim8 Nov 2025 5:06 PM ISTNew Delhi: Eli Lilly's diabetes and obesity drug Mounjaro (Tirzepatide) has become India's top-selling drug by value for October 2025, overtaking...
Obesity Discussions to Take Spotlight at RSSDI 2025; Experts to Delve into Tirzepatide's Dual Agonism in Metabolic Care Deeksha Bhandari4 Nov 2025 12:20 PM ISTThe topic of obesity and metabolic disease will take centre stage at the upcoming 53rd Annual Conference of the Research Society for the Study of...
Explainer video: Assess- Evaluating Patient Readiness for Diabetes- Management Strategies Deeksha Bhandari31 Oct 2025 12:01 PM ISTDiscussing weight with people living with type 2 diabetes can be difficult, but it is vital to improving care. Many patients with overweight or...
Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Farhat Nasim24 Oct 2025 11:36 AM ISTNew Delhi: In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla...
